Bladder function of patients with Parkinson's disease

Autor: Yosuke Aiba, Tomonori Yamanishi, Fuyuki Tateno, Tomoyuki Uchiyama, Masahiko Kishi, Ryuji Sakakibara, Takeki Nagao, Masashi Yano, Yohei Tsuyusaki, Tatsuya Yamamoto
Rok vydání: 2014
Předmět:
Zdroj: International Journal of Urology. 21:638-646
ISSN: 0919-8172
DOI: 10.1111/iju.12421
Popis: Bladder function of patients with Parkinson's disease alters significantly: the majority of patients have overactive bladder (urinary urgency/frequency) with little or no post-void residuals. This seems to be the result of an altered brain-bladder relationship, as in Parkinson's disease, the frontal-basal ganglia D1 dopaminergic circuit that normally suppresses the micturition reflex is altered. The pathophysiology of the bladder dysfunction in Parkinson's disease differs from that in multiple system atrophy; therefore, it might also aid in differential diagnosis. The effects of levodopa, the major drug to treat motor dysfunction, on the bladder in Parkinson's disease vary significantly; therefore, add-on therapy is often required. Anticholinergic drugs are the first-line treatment, with particular care for cognitive function in elderly patients. The second-line treatment includes serotonergics drug, desmopressin and others. Newer modalities include deep brain stimulation that improves the bladder in Parkinson's disease; and botulinum toxin is promising, particularly in difficult cases. These treatments might be beneficial in maximizing the patients' quality of life.
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje